3645-45-2

Basic information

• Product Name: 1,2-Benzenedicarboxylic acid dihydrazide
• Synonyms: 1,2-Benzenedicarboxylic acid dihydrazide
• CAS NO: 3645-45-2
• Molecular Formula: C₈H₁₀N₄O₂
• Molecular Weight: 194.1906
• Mol File: 3645-45-2.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,2-Benzenedicarboxylic acid dihydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenedicarboxylic acid dihydrazide(3645-45-2)
• EPA Substance Registry System: 1,2-Benzenedicarboxylic acid dihydrazide(3645-45-2)

Safety Data

• Hazardous Substances Data: 3645-45-2(Hazardous Substances Data)

Usage

General Description

1,2-Benzenedicarboxylic acid dihydrazide, also known as dihydrazide adipic acid, is a chemical compound with the formula C8H12N4O4. It is a white crystalline powder used in the production of polyimides, which are high-performance plastics with excellent thermal and chemical resistance. 1,2-Benzenedicarboxylic acid dihydrazide is often employed as a curing agent for epoxy resins and as a cross-linking agent for polymers. It is also utilized in the manufacturing of adhesives, coatings, and laminates due to its ability to improve the mechanical and thermal properties of the resulting materials. Additionally, this compound has potential applications in the pharmaceutical industry and as a corrosion inhibitor in various industrial processes.

Upstream product

• 131-11-3 phthalic acid dimethyl ester 
• 84-66-2 Diethyl phthalate 
• 81068-67-9 2-[2-(5-Fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-methylsulfanyl-ethyl]-isoindole-1,3-dione 
• 473437-99-9 2-(8-oxo-8H-indeno[1,2-c]thiophen-1-yl)isoindoline-1,3-dione 
• 5460-29-7 2-(3-bromopropyl)isoindole-1,3-dione 
• 281197-48-6 Np-(4-fluorobenzyl)-Na-phthaloyihistamine 
• 191544-76-0 Np-(4-cyanobenzyl)-Na-phthaloylhistamine 
• 81099-39-0 Acetic acid 2-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethylsulfanyl]-2-(5-iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-ethyl ester 
• 52096-60-3 2-<2-(Methylthio)ethyl>-1H-isoindole-1,3(2H)-dione 
• 64-17-5 ethanol 
• 7803-57-8 hydrazine hydrate 
• 81068-55-5 2-{2-[2-Hydroxy-1-(5-iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-ethylsulfanyl]-ethyl}-isoindole-1,3-dione 
• 81068-54-4 2-{2-[1-(5-Fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-hydroxy-ethylsulfanyl]-ethyl}-isoindole-1,3-dione 
• 81068-66-8 2-[2-(5-Iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-methylsulfanyl-ethyl]-isoindole-1,3-dione 

Downstream Products

• 1445-69-8 2,3-dihydrophthalazine-1,4-dione 
• 112008-80-7 disalicylaldehyde phthaloyldihydrazone 
• 15100-70-6 Benzol-1,2-dicarbonsaeure-bis-dichloracetylhydrazid 
• 1384973-99-2 13-(4-hydroxyphenyl)-3, 3-dimethyl-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H, 13H)-trione 
• 1017238-96-8 13-(4-fluorophenyl)-3,3-dimethyl-2,3,4,6,11,13-hexahydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
• 1204395-07-2 3,4-dihydro-3,3-dimethyl-13-(4-methoxyphenyl)-2Hindazolo[2,1-b]phthalazine-1,6,11(13H)-trione 
• 1017238-97-9 3,3-dimethyl-13-(4-nitrophenyl)-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1415214-11-7 3,3-dimethyl-13-(2-nitrophenyl)-2,3,4,6,11,13-hexahydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
• 1017238-93-5 3,4-dihydro-3,3-dimethyl-13-phenyl-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1017238-94-6 3,3-dimethyl-13-(4-chlorophenyl)-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1017238-95-7 3,4-dihydro-3,3-dimethyl-13-(4-bromophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione 
• 1017239-00-7 3,3-dimethyl-13-(4-methylphenyl)-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione 
• 1173891-44-5 13-(2,4-dichlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione 
• 1017238-98-0 13-(2-chlorophenyl)-3,3-dimethyl-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 

Relevant articles and documents

NOVEL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

Novel compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl-protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human.

CHELATING COMPOUNDS, THEIR COMPLEXES WITH PARAMAGNETIC METALS

Compounds able to chelate bi- and trivalent paramagnetic metal ions, their chelated complexes with said metal ions and the physiologically compatible salts thereof, as well as the use thereof as contrast agents in the technique known as “Magnetic Resonanc

N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them

The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.